- increased body weight / IMPC
- abnormal lens morphology / IMPC
- cataract / IMPC
- abnormal urination / IMPC
- decreased circulating triglyceride level / IMPC
- abnormal bone mineralization / IMPC
- thrombocytopenia / IMPC
- increased lean body mass / IMPC
- abnormal vertebral arch morphology / IMPC
- vertebral fusion / IMPC
- abnormal behavior / IMPC
- decreased T cell number / IMPC
- decreased circulating cholesterol level / IMPC
- increased total body fat amount / IMPC
- increased grip strength / IMPC
- increased bone mineral content / IMPC
- preweaning lethality, complete penetrance / IMPC
C57BL/6NTac-Xbp1tm1a(EUCOMM)Wtsi/IcsOrl
Status | Available to order |
EMMA ID | EM:07516 |
Citation information | RRID:IMSR_EM:07516 Research Resource Identifiers (RRID) are persistent unique ID numbers assigned to help researchers cite key resources (e.g. antibodies, model organisms and software projects) in the biomedical literature to improve transparency and reproducibility in research. See https://www.rrids.org/ for more information. |
International strain name | C57BL/6NTac-Xbp1tm1a(EUCOMM)Wtsi/IcsOrl |
Alternative name | EPD0038_2_E10 |
Strain type | Targeted Mutant Strains |
Allele/Transgene symbol | Xbp1tm1a(EUCOMM)Wtsi |
Gene/Transgene symbol | Xbp1 |
Disclaimer | Please note that for EUCOMM and KOMP-CSD mice supplied to the scientific community by INFRAFRONTIER/EMMA:
|
Information from provider
Provider | ICS, Institut Clinique de la Souris |
Provider affiliation | ICS, Institut Clinique de la Souris |
Genetic information | This mouse line originates from EUCOMM ES clone EPD0038_2_E10. For further details on the construction of this clone see the page at the IMPC portal. |
Phenotypic information | Potential phenotyping data in the IMPC portal |
References | None available |
Information from EMMA
Archiving centre | Institut de Transgenose, INTRAGENE, Orléans, France |
Animals used for archiving | heterozygous C57BL/6NTac males, wild-type C57BL/6NTac females |
Stage of embryos | 8-cell |
Disease and phenotype information
IMPC phenotypes (allele matching)
IMPC phenotypes (gene matching)
- decreased circulating triglyceride level / IMPC
- abnormal behavior / IMPC
- decreased T cell number / IMPC
- thrombocytopenia / IMPC
- increased grip strength / IMPC
- increased mean corpuscular volume / IMPC
- preweaning lethality, complete penetrance / IMPC
- increased total body fat amount / IMPC
- increased mean corpuscular hemoglobin / IMPC
- persistence of hyaloid vascular system / IMPC
- decreased leukocyte cell number / IMPC
- cataract / IMPC
- decreased large unstained cell number / IMPC
- decreased red blood cell distribution width / IMPC
- decreased circulating cholesterol level / IMPC
- increased lean body mass / IMPC
- abnormal lens morphology / IMPC
- vertebral fusion / IMPC
- decreased lymphocyte cell number / IMPC
- increased bone mineral content / IMPC
- abnormal bone mineralization / IMPC
- increased body weight / IMPC
- abnormal vertebral arch morphology / IMPC
- abnormal urination / IMPC
MGI phenotypes (gene matching)
- abnormal heart development / MGI
- thin ventricular wall / MGI
- enlarged pericardium / MGI
- absent trabeculae carneae / MGI
- decreased cell proliferation / MGI
- abnormal liver development / MGI
- liver hypoplasia / MGI
- small liver / MGI
- wavy neural tube / MGI
- anemia / MGI
- impaired hematopoiesis / MGI
- abnormal blood vessel morphology / MGI
- decreased embryo size / MGI
- anoxia / MGI
- pallor / MGI
- increased hepatocyte apoptosis / MGI
- embryonic growth retardation / MGI
- decreased hepatocyte proliferation / MGI
- abnormal extraembryonic tissue physiology / MGI
- myocardial necrosis / MGI
- decreased embryo weight / MGI
- embryonic lethality during organogenesis, complete penetrance / MGI
- embryo tissue necrosis / MGI
Information on how we integrate external resources can be found here
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).